Usual Ductal Hyperplasia (UDH)
暂无分享,去创建一个
[1] I. Ellis,et al. Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile , 2016, Histopathology.
[2] C. Cohen,et al. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ. , 2016, Archives of pathology & laboratory medicine.
[3] M. Troxell,et al. Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions , 2014, Modern Pathology.
[4] V. Eusebi,et al. Epitheliosis, infiltrating epitheliosis, and radial scar. , 2010, Seminars in diagnostic pathology.
[5] J. Rabban,et al. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. , 2006, Human pathology.
[6] A. Bankfalvi,et al. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast , 2000, Histopathology.